Central serous chorioretinopathy (CSC) affects roughly 10 men and two women per 100,000 people, and they are often younger, working-aged individuals with high visual demands. Randomized clinical trials in CSC are scarce and typically evaluate dozens of patients1-12 (Table, page 11) rather than the hundreds or even thousands of patients evaluated in trials for age-related macular degeneration (A...

Funding/Support: This work was supported in part by an unrestricted grant from Research to Prevent Blindness, Inc, New York, New York, and the Jack A. and Elaine D. Klieger Professorship, Medical College of Wisconsin, Milwaukee. Online-Only Material: The video is available at http: //www.archophthalmol.com. Additional Contributions: Deb Wahlers and Adam Dubis provided technical assistance in pr...

Central serous chorioretinopathy (CSC) is a retinal disorder that primarily affects young (20- to 50-year-old) white men, although it is seen occasionally in older patients and females. CSC is characterized by avascular focal leakage through the retinal pigment epithelium (RPE), resulting in serous detachment of the neurosensory retina. The course is usually self-limiting and in most cases reso...

Central serous chorioretinopathy (CSC) is a retinal disorder that primarily affects young (20to 50-year-old) white men, although it is seen occasionally in older patients and females. CSC is characterized by avascular focal leakage through the retinal pigment epithelium (RPE), resulting in serous detachment of the neurosensory retina. The course is usually self-limiting and in most cases resolv...

Despite numerous studies describing predominantly its demography and clinical course, many aspects of central serous chorioretinopathy (CSCR) remain unclear. Perhaps the major impediment to finding an effective therapy is the difficulty of performing studies with large enough cohorts, which has meant that clinicians have focused more on therapy than on a deeper understanding of the pathogenesis...

PURPOSE To report a patient erroneously diagnosed with tuberculous choroiditis who was accordingly treated with long term steroids which in turn, worsened the actual disease process that turned out to be central serous chorioretinopathy (CSC). CASE REPORT A 59-year-old Caucasian man developed a chorioretinal disease in his right eye in 1997. Having a positive tuberculin skin test, tuberculous...

Central serous chorioretinopathy (CSC) was first described by von Graefe in 1866, who named it as ‘relapsing central luetic retinitis’.[1] A variety of names have since been used to describe this idiopathic detachment of the neurosensory retina.[2] It was more than 100 years later that Maumenee, using fluorescein angioscopy, noted that the detachment of the macula resulted from a leak at the le...